Everyone knows the benefits of green tea. From aiding weight loss to reducing the risk of heart disease, green tea is touted as a wellness elixir.

So, can a cup of green tea help fight COVID-19? New study suggests yes!

According to the study published in the journal “RSC Advances”, green tea could help fight COVID-19. A compound found in green tea called gallocatechin may help in the development of a drug that can fight SARS-CoV-2.

An academic from Swansea University is studying how green tea could give rise to a drug capable of fighting this deadly disease. Dr Suresh Mohankumar carried out research with colleagues in India during his time at JSS College of Pharmacy, JSS Academy of Higher Education and Research in Ooty before taking up his current role at Swansea University Medical School.

He said: “Nature’s oldest pharmacy has always been a treasure trove of potential new drugs and we wondered if any of these compounds could help us fight the Covid-19 pandemic?”

Researchers screened and sorted a library of naturally occurring compounds already known to be active against other coronaviruses using an artificial intelligence-assisted computer program.

“Our results suggest that one of the compounds in green tea could fight the coronavirus behind COVID-19,” Dr. Mohankumar said. Associate Professor Dr Mohankumar stressed that the research was still in its infancy and far from any kind of clinical application.

“The compound that our model predicts as the most active is gallocatechin, which is present in green tea and could be readily available, accessible and affordable. More research is now needed to show whether it can be proven clinically effective and safe to prevent or treat COVID-19, ”noted Dr. Mohankumar.

“This is still a preliminary step, but it could be a potential avenue to fight the devastating Covid-19 pandemic,” he added. Dr Mohankumar has worked in pharmacy education, research and administration around the world for over 18 years and recently moved to Swansea to join his new MPharm program.

Professor Andrew Morris, Head of Pharmacy, said: “This is fascinating research showing that natural products remain an important source of lead compounds in the fight against infectious diseases. joins the Pharmacy team. “

Dr Mohankumar added that he now looks forward to seeing how the work can be developed, “There is a need now for appropriate preclinical and clinical studies and we would welcome potential collaborators and partners to help move this work forward.”